Literature DB >> 24756900

CSF otorhinorrhea in a child with inner ear dysplasia: diagnosis with T2-weighted and intrathecal contrast-enhanced MR cisternography.

Elnur Mehdi1, Alpay Alkan, Huseyin Yetis, Ayse Aralasmak, Huseyin Ozdemir.   

Abstract

During the follow-up of recurrent pneumonia in a 9-month-old girl, rhinorrhea with discharge of a positional and intermittent nature was discovered. Radiological assessment was requested to detect any skull base openings and cerebrospinal fluid (CSF) leakage. T2-weighted MR cisternography showed bilateral inner ear dysplasia, communication of the internal auditory canal with the vestibule, and effusion in the right middle ear. Intrathecal contrast-enhanced MR cisternography revealed a CSF fistula from the right internal auditory canal to the Eustachian tube. The patient was operated upon on the right side, and the presence of a CSF leak near the oval window was confirmed. No adverse effects were seen during the short-term and long-term follow-up. Diagnosing this case required special attention, careful examination, and relevant investigations to find the site of CSF leakage in this patient with bilateral inner ear dysplasia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24756900     DOI: 10.1007/s11604-014-0316-y

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  8 in total

1.  A new classification for cochleovestibular malformations.

Authors:  Levent Sennaroglu; Isil Saatci
Journal:  Laryngoscope       Date:  2002-12       Impact factor: 3.325

2.  Intrathecal gadolinium (gadopentetate dimeglumine) enhanced magnetic resonance myelography and cisternography: results of a multicenter study.

Authors:  E Turgut Tali; Nil Ercan; Gaida Krumina; Mohammed Rudwan; Angel Mironov; Qing Yu Zeng; J Randy Jinkins
Journal:  Invest Radiol       Date:  2002-03       Impact factor: 6.016

3.  T2-weighted vs. intrathecal contrast-enhanced MR cisternography in the evaluation of CSF rhinorrhea.

Authors:  Gaye Ecin; A Yusuf Oner; Nil Tokgoz; Murat Ucar; Sukru Aykol; Turgut Tali
Journal:  Acta Radiol       Date:  2013-04-30       Impact factor: 1.990

4.  Neurotoxic manifestations of an overdose intrathecal injection of gadopentetate dimeglumine.

Authors:  Kwan-Woong Park; Soo-Bin Im; Bum-Tae Kim; Sun-Chul Hwang; Jong-Sun Park; Won-Han Shin
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

5.  Cisternography and ventriculography gadopentate dimeglumine-enhanced MR imaging in pediatric patients: preliminary report.

Authors:  A Muñoz; J Hinojosa; J Esparza
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

6.  Intrathecal gadolinium (gadopentetate dimeglumine)-enhanced MR cisternography used to determine potential communication between the cerebrospinal fluid pathways and intracranial arachnoid cysts.

Authors:  E Turgut Tali; Nil Ercan; Memduh Kaymaz; Aydin Pasaoglu; J Randy Jinkins
Journal:  Neuroradiology       Date:  2004-09       Impact factor: 2.804

7.  From labyrinthine aplasia to otocyst deformity.

Authors:  Anja Maria Giesemann; Friedrich Goetz; Jürgen Neuburger; Thomas Lenarz; Heinrich Lanfermann
Journal:  Neuroradiology       Date:  2009-10-02       Impact factor: 2.804

8.  Intrathecal gadolinium-enhanced MR cisternography in the evaluation of CSF leakage.

Authors:  H Selcuk; S Albayram; H Ozer; S Ulus; G Z Sanus; M Y Kaynar; N Kocer; C Islak
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-17       Impact factor: 4.966

  8 in total
  2 in total

1.  Spinal Cerebrospinal Fluid Leakage in Spontaneous Intracranial Hypotension: An Intrathecal Gadolinium Enhanced MR-Myelography Study.

Authors:  Hakan Cebeci; Cem Bilgin; Selman Candan; Aylin Bican Demir; Bahattin Hakyemez
Journal:  J Belg Soc Radiol       Date:  2020-01-30       Impact factor: 1.894

2.  Children With Intracranial Arachnoid Cysts: Classification and Treatment.

Authors:  Zhen Tan; Yongxin Li; Fengjun Zhu; Dongdong Zang; Cailei Zhao; Cong Li; Dan Tong; Heye Zhang; Qian Chen
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.